Role of CD19 signal transduction in B cell biology

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 45-54

  Carter, Robert H ^a   Wang, Yue ^a   Brooks, Stephen ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antibodies; B lymphocytes; Calcium; CD19; Signal transduction

Indexed keywords

CD19 ANTIGEN; TYROSINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CYTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 0036394241     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:26:1-3:045     Document Type: Article

References (51)

1. Fearon DT, Carter RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1995;13:127-149.
2. Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn J, Fearon DT: Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 1993;178:1407-1417.
3. Fearon DT, Carroll MC: Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000;18:393-422.
4. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39-50.
5. Sato S, Ono N, Steeber D, Pisetsky D, Tedder T: CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 1996;157:4371-4378.
6. Martin F, Kearney JF: Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12:39-49.
7. Martin F, Kearney JF: B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol Rev 2000;175:70-79.
8. Fischer MB, Goerg S, Shen L, Prodeus AP, Goodnow CC, Kelsoe G, Carroll MC: Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 1998;280:582-5.
9. Molina H, Holers V, Li B, Fang YF, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr R, Chaplin D: Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996;93:3357-3361.
10. Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992;256:105-107.
11. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VLJ, Fearon DT: CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998;8:635-645.
12. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348-350.
13. Baiu DC, Prechl J, Tchorbanov A, Molina HD, Erdei A, Sulica A, Capel PJ, Hazenbos WL: Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J Immunol 1999;162:3125-3130.
14. Rickert RC, Rajewsky K, Roes J: Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995;376:352-355.
15. Ochsenbein AF, Pinschewer DD, Odermatt B, Carroll MC, Hengartner H, Zinkernagel RM: Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 1999;190:1165-1174.
16. Fehr T, Rickert RC, Odermatt B, Roes J, Rajewsky K, Hengartner H, Zinkernagel RM: Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med 1998;188:145-155.
17. Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K: Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000;165:6635-6643.
18. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997;186:1923-1931.
19. Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT: The CD19 complex of B lymphocytes: activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol 1991;147:3663-3671.
20. Cherukuri A, Cheng P, Sohn H, Pierce S: The CD19/CD21 Complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 2001;14:168-179.
21. Zhou LJ, Ord DC, Hughes AL, Tedder TF: Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes: conservation of the extensive cytoplasmic domain. J Immunol 1991;147:1424-1432.
22. Tuveson DA, Carter RH, Soltoff SP, Fearon DT: CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993;260:986-989.
23. Scharenberg AM, Kinet JP: PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 1998;94:5-8.
24. Li X, Sandoval D, Freeberg L, Carter RH: Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J Immunol 1997;158:5649-5657.
25. Brooks SR, Li X, Volanakis EJ, Carter RH: Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. J Immunol 2000;164:3123-3131.
26. Fujimoto M, Fujimoto Y, Poe J, Jansen P, Lowell C, DeFranco A, Tedder T: CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 2000;13:46-57.
27. Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA: Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol 1995;25:2978-2984.
28. Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT: Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 1988;141:457-463.
29. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT: Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 1991;173:55-64.
30. Li X, Carter RH: Convergence of CD19 and B cell antigen receptor signals in the ERK2 activation cascade. J Immunol 1998;161:5901-5908.
31. Li X, CarterRH: CD19 signal transduction in normal human B cells: linkage to downstream pathways requires phosphatidylinositol 3-kinase, protein kinase C and Ca2+. Eur J Immunol 2000;30:1576-1586.
32. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995;374:470-473.
33. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajwsky K, Tybulewicz VLJ: Defective antigen-receptor mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-470.
34. Crespo P, Bustelo X, Aaroson D, Coso O, Lopez-Barahona M, Barbacid M, Gutkind J: Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 1996;13:455-460.
35. 2+ mobilization. J Exp Med 1997;186:1897-1910.
36. Buhl AM, Cambier JC: Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J Immunol 1999;162:4438-4446.
37. Fujimoto M, Poe JC, Inaoki M, Tedder TF: CD19 regulates B lymphocyte responses to transmembrane signals. Semin Immunol 1998;10:267-277.
38. Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF: CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 1999;162:7088-7094.
39. Carter RH, Park DG, Rhee SG, Fearon DT: Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes. Proc Natl Acad Sci USA 1991;88:2745-2749.
40. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
41. Schonwasser DC, Marias RM, Marchall CJ, Parker PJ: Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 1998;18:790-798.
42. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ: Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-2045.
43. Barbazuk SM, Gold MR: Protein kinase C-delta is a target of B-cell antigen receptor signaling. Immunol Lett 1999;69:259-267.
44. Morrow TA, Muljo SA, Zhang J, Hardwick JM, Schlissel MS: Pro11B-cell-specific transcription and proapoptotic function of protein kinase Ceta. Mol Cell Biol 1999;19:5608-5618.
45. King LB, Norvell A, Monroe JG: Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells. J Immunol 1999;162:2655-2662.
46. Chan VW, Mecklenbrauker I, Su I, Texido G, Leitges M, Carsetti R, Lowell CA, Rajewsky K, Miyake K, Tarakhovsky A: The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med 1998;188:93-101.
47. Deehan MR, Harnett MM, Harnett W: A filarial nematode secreted product differentially modulates expression and activation of protein kinase C isoforms in B lymphocytes. J Immunol 1997;159:6105-6111.
48. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A: Immunodeficiency in protein kinase cbeta-deficient mice. Science 1996;273:788-791.
49. Carballo E, Colomer D, Vives-Corrons JL, Blackshear PJ, Gil J: Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). J Immunol 1996;156:1709-1713.
50. Sidorenko S, Law C-L, Klaus S, Chandran K, Takata M, Kurosaki T, Clark E: Protein kinase C μ associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 1996;5:353-363.
51. Uckun F, Burkhardt AL, Jarvis L, Stealey B, Dibirdik I, Myers DE, Tuel-Ahlgren L, Bolen JB: Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J Biol Chem 1993;268:21,172-21,184.